About lab
Systems modelling of the EGFR-PYK2-c-Met interaction network predicted and prioritized synergistic drug combinations for Triple-negative breast cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageshin-2018-egfr-pyk2-c-met-interaction-network-model-lab
Created2026-05-16
Updated2026-05-16
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "egfrtot_source_parameter",
"label": "EGFRtot source parameter",
"units": "native SBML value",
"default": 398.107,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egfrtot_source_parameter",
"description": "EGFRtot source parameter. Maps to bundled SBML parameter `EGFRtot`."
},
{
"name": "ca_egf_source_parameter",
"label": "CaEGF source parameter",
"units": "native SBML value",
"default": 0.0891251,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.ca_egf_source_parameter",
"description": "CaEGF source parameter. Maps to bundled SBML parameter `caEGF`."
},
{
"name": "egf_source_parameter",
"label": "EGF source parameter",
"units": "native SBML value",
"default": 10,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egf_source_parameter",
"description": "EGF source parameter. Maps to bundled SBML parameter `EGF`."
},
{
"name": "initial_pegfr",
"label": "PEGFR",
"units": "native SBML value",
"default": 0.109014,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_pegfr",
"description": "Initial PEGFR. Sets the initial value of bundled SBML symbol `pEGFR`."
},
{
"name": "initial_egfrub",
"label": "EGFRub",
"units": "native SBML value",
"default": 6.93991,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_egfrub",
"description": "Initial EGFRub. Sets the initial value of bundled SBML symbol `EGFRub`."
},
{
"name": "initial_perk",
"label": "PERK",
"units": "native SBML value",
"default": 0.669043,
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.initial_perk",
"description": "Initial PERK. Sets the initial value of bundled SBML symbol `pERK`."
}
],
"outputs": [
{
"name": "pegfr",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pegfr",
"description": "PEGFR observable. Maps to SBML symbol `pEGFR`."
},
{
"name": "egfrub",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.egfrub",
"description": "EGFRub observable. Maps to SBML symbol `EGFRub`."
},
{
"name": "perk",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.perk",
"description": "PERK observable. Maps to SBML symbol `pERK`."
},
{
"name": "pstat3",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pstat3",
"description": "PSTAT3 observable. Maps to SBML symbol `pSTAT3`."
},
{
"name": "stat3u_stattic",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.stat3u_stattic",
"description": "STAT3uStattic observable. Maps to SBML symbol `STAT3uStattic`."
},
{
"name": "pyk2",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.pyk2",
"description": "PYK2 observable. Maps to SBML symbol `PYK2`."
},
{
"name": "state",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Shin_2018_EGFR-PYK2-c-Met interaction network_model Lab",
"models": [
{
"path": "owned/models/oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model",
"alias": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_state"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.state"
},
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_summary"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model_species_labels"
],
"from": "oncology_sbml_shin_2018_egfr_pyk2_c_met_interaction_network_mo_biomd0000000826_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Systems modelling of the EGFR-PYK2-c-Met interaction network predicted and prioritized synergistic drug combinations for Triple-negative breast cancer. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.